The findings that mutations in PS1, PS2, and APP invariably cause early-onset AD (see above) has led to the systematic measurement of several fluid and imaging biomarkers to establish an approximate sequence of the biological changes that precede symptoms [69]. The gene discussed is PSEN2; the disease is Alzheimer disease.